0 false false false false false false false false false true false false false false false false No description of principal activity 2022-01-20 Sage Accounts Production Advanced 2021 - FRS102_2021 142 142 142 xbrli:pure xbrli:shares iso4217:GBP 13861609 2022-01-20 2023-01-31 13861609 2023-01-31 13861609 bus:Director1 2022-01-20 2023-01-31 13861609 bus:Director2 2022-01-20 2023-01-31 13861609 core:PatentsTrademarksLicencesConcessionsSimilar 2022-01-20 2023-01-31 13861609 core:WithinOneYear 2023-01-31 13861609 core:ShareCapital 2023-01-31 13861609 core:RetainedEarningsAccumulatedLosses 2023-01-31 13861609 core:PatentsTrademarksLicencesConcessionsSimilar 2023-01-31 13861609 bus:Director2 2023-01-31 13861609 bus:SmallEntities 2022-01-20 2023-01-31 13861609 bus:AuditExemptWithAccountantsReport 2022-01-20 2023-01-31 13861609 bus:FullAccounts 2022-01-20 2023-01-31 13861609 bus:SmallCompaniesRegimeForAccounts 2022-01-20 2023-01-31 13861609 bus:PrivateLimitedCompanyLtd 2022-01-20 2023-01-31
COMPANY REGISTRATION NUMBER: 13861609
The Ocularium Ltd.
Filleted Unaudited Financial Statements
For the period ended
31 January 2023
The Ocularium Ltd.
Statement of Financial Position
31 January 2023
31 Jan 23
Note
£
Fixed assets
Intangible assets
4
142
Tangible assets
5
1,264
-------
1,406
Current assets
Debtors
6
4,127
Cash at bank and in hand
265
-------
4,392
Creditors: amounts falling due within one year
7
43,459
--------
Net current liabilities
39,067
--------
Total assets less current liabilities
( 37,661)
--------
Capital and reserves
Called up share capital
1
Profit and loss account
( 37,662)
--------
Shareholders deficit
( 37,661)
--------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
For the period ending 31 January 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
The Ocularium Ltd.
Statement of Financial Position (continued)
31 January 2023
These financial statements were approved by the board of directors and authorised for issue on 12 October 2023 , and are signed on behalf of the board by:
E J Mason
Director
Company registration number: 13861609
The Ocularium Ltd.
Notes to the Financial Statements
Period from 20 January 2022 to 31 January 2023
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 34 Montagu Square, London, W1H 2LJ.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Intangible assets
Intangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated amortisation and impairment losses. Any intangible assets carried at revalued amounts, are recorded at the fair value at the date of revaluation, as determined by reference to an active market, less any subsequent accumulated amortisation and subsequent accumulated impairment losses.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Equipment
-
25% straight line
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument.
4. Intangible assets
Patents, trademarks and licences
£
Cost
Additions
142
----
At 31 January 2023
142
----
Amortisation
At 20 January 2022 and 31 January 2023
----
Carrying amount
At 31 January 2023
142
----
5. Tangible assets
Equipment
£
Cost
At 20 January 2022
Additions
1,291
-------
At 31 January 2023
1,291
-------
Depreciation
At 20 January 2022
Charge for the period
27
-------
At 31 January 2023
27
-------
Carrying amount
At 31 January 2023
1,264
-------
6. Debtors
31 Jan 23
£
Other debtors
4,127
-------
7. Creditors: amounts falling due within one year
31 Jan 23
£
Trade creditors
8,697
Other creditors
34,762
--------
43,459
--------
8. Directors' advances, credits and guarantees
During the period the directors entered into the following advances and credits with the company:
31 Jan 23
Balance brought forward
Advances/ (credits) to the directors
Balance outstanding
£
£
£
D Mason
( 10,002)
( 10,002)
----
--------
--------